VETERINARY COMPOSITIONS OF MODIFIED VIRAL PARTICLES OF CMV ANTIGENS AND CANINE IL-1β MUTEIN

AR135404A1Pending Publication Date: 2026-09-02ELANCO US INC +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ARP20250100603
Authority / Receiving Office: AR · AR
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-03-06
Filing Date: 2025-03-05
Publication Date: 2026-09-02

Application Information

Patent Timeline

06 Mar 2024

Priority

05 Mar 2025

Application

ARP20250100603

02 Sep 2026

Publication

AR135404A1

IPC: A61K39/00; A61K39/385; A61K47/64; A61P37/06; C12N15/70

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.

Claims

The present invention relates to compositions comprising modified virus-like particles (VLPs) of cucumber mosaic virus (CMV), and in particular to modified CMV VLPs comprising chimeric CMV polypeptides comprising a stretch of consecutive negative amino acids selected from aspartic acid and / or glutamic acid to which canine interleukin-1β mutain antigens, cIL-1β-D145X antigens, are attached, as well as to pharmaceutical compositions thereof, compositions preferably serving as vaccines to generate immune responses, in particular antibody responses, against cIL-1β.